Skip to Main Content

An official website of the United States government

Explore the HIP Breast Cancer Screening Trial
Access to Data

Here you can browse the complete list of projects for HIP Breast Cancer Screening Trial whose requests for data/biospecimens were approved.

Results: 8 (Showing 1 to 8)
Name Principal Investigator Institution Study Date Approved Project ID
Surrogate endpoints for cancer screening trials Adam Brentnall Queen Mary University of London HIPB Nov 14, 2024 HIPB-15
Heterogeneous treatment effect estimation using instrumental variable in time-to-event data Uri Shalit Technion - Israel Institute of Technology HIPB May 13, 2024 HIPB-13
Treatment effect in a proportional hazards model with instrumental variables lorenzo tedesco KU LEUVEN HIPB Dec 5, 2022 HIPB-10
Use of prescriptive analytics in the desing of dynamic treatment regimes for breast cancer. Gustavo Mendoza Olguin Autonomous University of Puebla HIPB Jun 14, 2022 HIPB-9
Designing personal treatment for breast cancer Nan Wang Dalian University of Technology HIPB Mar 25, 2022 HIPB-8
Epidemiologic investigation of breast cancer cases diagnosed in a large histopathological practice Axel Niendorf MVZ Prof. Dr. med. A. Niendorf Pathologie Hamburg-West GmbH HIPB Sep 17, 2021 HIPB-6
Quantitative analysis on the design of the project of multi-cancer early detection trial Ping Hu NCI HIPB Jul 30, 2021 HIPB-4
Nonparametric instrumental regression with competing risks data Ingrid Van Keilegom Katholieke Universiteit Leuven HIPB Mar 1, 2021 HIPB-2